News

Conquer Cancer, the ASCO Foundation, is celebrating the life of Marc Citron, MD. Dr. Citron was a research pioneer and Conquer Cancer donor, who died February 25, 2020, from recurrent glioblastoma. He was 72.

“Mark was a caring colleague, devoted clinician, collaborative researcher, and career-long ASCO member who made you feel better whenever you spoke with him,” said Clifford A. Hudis, MD, FACP, FASCO, ASCO CEO, and executive vice chair, Conquer Cancer Board of Directors. “He was thoughtful, considerate, and, most of all, obsessively devoted to the well-being of his patients.”

Researchers from The University of Texas MD Anderson Cancer Center published a study in Nature Medicine showing promising results for patients with non-small cell lung cancer (NSCLC).

Stephen A. Cannistra, MD, FASCO, was among the first scientists to define the mechanisms by which ovarian cancer cells spread throughout the peritoneal cavity. His work further defined the role of apoptosis in mediating chemotherapy-induced killing of ovarian cancer cells, as well as the possibility of using gene expression arrays to predict chemotherapy responsiveness in this disease. In the clinic, he was one of the first to show that the anti-angiogenic agent bevacizumab was active in patients with recurrent disease, paving the way for using this drug in the first-line setting.